Why are the low-energy protein normal modes evolutionarily conserved?

Artikel in diesem Heft

1. Preface
2. Natural products from Brazilian biodiversity as a source of new models for medicinal chemistry
3. Bioactive cubitane diterpenoids from a Colombian gorgonian species of the genus Eunicea
4. Structure- and ligand-based drug design approaches for neglected tropical diseases
5. First total synthesis of the (±)-2-methoxy-6-heptadecynoic acid and related 2-methoxylated analogs as effective inhibitors of the Leishmania topoisomerase IB enzyme
6. Potent and selective 2-oxoamide inhibitors of phospholipases A2 as novel medicinal agents for the treatment of inflammatory diseases
7. Structural and functional impairments of polysialic acid (polySia)-neural cell adhesion molecule (NCAM) synthesized by a mutated polysialyltransferase of a schizophrenic patient
8. Balancing life with glycoconjugates: Monitoring unfolded protein response-mediated anti-angiogenic action of tunicamycin by Raman spectroscopy
9. Exploring metal-driven stereoselectivity of glycopeptides by free-energy calculations
10. Why are the low-energy protein normal modes evolutionarily conserved?
11. IUPAC/CITAC Guide: Investigating out-of-specification test results of chemical composition based on metrological concepts (IUPAC Technical Report)